Enterome, a gut healthcare company backed by Natixis venture unit Seventure, raises the funds after a $1.5m seed round from Inra Transfert, the French National Institute in Agronomic Research's tech transfer organisation.
Enterome, a company focused on diseases of the gut, has raised €5m ($6.6m). The company’s series A was co-led by Seventure, part of France-based bank Natixis, and venture firm Lundbeckfond Ventures. It previously raised €1.5m from Seventure Partners and Inra Transfert, the French National Institute in Agronomic Research’s tech transfer organisation. Gérard Jacquin, president of…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
